Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Drug Development

      Agentic AI in Pharma: Transforming R&D to Commercialisation

      Clinical Trials
      The pharmaceutical industry is experiencing an unprecedented transformation driven by technological innovation and digital disruption. Among these technological advances, agentic Artificial Intelligence (AI) can...

      New Software to Predict Cell Activity for Cancer Research

      News
      Researchers have developed a method to predict the cell activity in tissues over time. The method involves new software that combines genomics technologies with...

      Biosimulation Market Size and Growth Projections: 2025–2030

      Drug Development
      In the rapidly evolving landscape of drug discovery and development, biosimulation has emerged as an indispensable tool that stands at the intersection of computational...

      The Future of Clinical Trial Data in Decentralisation Models

      Clinical Trials
      The landscape of clinical research is undergoing a seismic shift, powered by technological advancement, shifting patient expectations, and a worldwide drive for more effective...

      GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology

      Drug Development
      GSK plc announced it has entered into agreements with Hengrui Pharma to develop up to 12 innovative medicines, adding significant new growth opportunities to...

      Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition

      Clinical Trials
      Aptar Pharma, a global leader in drug delivery and active material science solutions and services, announced its acquisition of the clinical trial materials manufacturing...

      FDA Accepts BLA for Recommended Biosimilar to Simponi

      FDA Approvals
      Bio-Thera Solutions announced that the FDA has accepted its Biologics License Application (BLA) for BAT2506, a proposed biosimilar to Simponi® (golimumab).  The FDA goal...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

      System

      Resources

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.